scoping-review-finds-existing-questionnaires-miss-key-rare-disease-care-domains
Scoping Review Finds Existing Questionnaires Miss Key Rare Disease Care Domains

Scoping Review Finds Existing Questionnaires Miss Key Rare Disease Care Domains

A scoping literature review analyzing sixty-one peer-reviewed articles and conference abstracts has established an initial structured definition of patient-reported experiences for individuals living with rare diseases receiving secondary and tertiary healthcare. The research team identified eleven operational domains comprising seventy-one individual care categories across Western healthcare settings, but discovered that none of the forty-two existing questionnaires evaluate all eleven domains or possess comprehensive validation across rare conditions. Published in the Orphanet Journal of Rare Diseases, the investigation systematically examined how patients and their family carers navigate specialized hospital environments, contrasting documented priorities with assessment tools currently employed by health systems. Although healthcare experience has become a cornerstone indicator of clinical quality, the authors observed that evaluative frameworks remain fragmented, heavily concentrated on a minuscule fraction of known conditions, and largely unvalidated beyond single diseases. Consequently, specialized institutions lack unified instruments to measure how effectively hospital care meets the complex needs of rare disease communities.

To map the landscape of rare disease healthcare experiences, the researchers implemented a scoping review protocol adhering to the PRISMA Extension for Scoping Reviews across Medline via PubMed, Embase, and CINAHL. The search spanned publications released between January 2005 and September 2022, focusing specifically on empirical studies conducted in English within Western nations, defined as Europe, the United States, Canada, Australia, and New Zealand. The investigators utilized a search string combining descriptors for rare and complex disorders, including specific terms for two prevalent conditions from each of the twenty-four European Reference Networks, alongside terminology relating to patient experience and care quality. After retrieving an initial pool of 4,763 records, two independent reviewers performed two-stage screening on the Covidence platform, evaluating titles and abstracts before subjecting 282 potentially eligible papers to full-text assessment against explicit eligibility criteria. Disagreements were resolved through consensus or adjudication by a third reviewer, identifying sixty-one eligible publications, comprising forty-six full-text articles and fifteen conference abstracts.

The analytical framework used to classify patient experiences originated from the Patient-Reported Indicator Surveys initiative coordinated by the Organisation for Economic Co-operation and Development. The researchers initially adapted nine core domains and forty-two categories from the primary care survey of that initiative, focusing on Access, Comprehensiveness, Continuity, Coordination, Patient-centredness, Safety, Self-management support, Trust, and Overall perceived quality of care. However, during data extraction, the authors determined that the primary care focus of the international indicator model failed to encompass critical challenges inherent to managing rare conditions within specialized hospital units. Through an inductive thematic analysis validated across the multidisciplinary research team, the authors formulated two additional core domains: Diagnosis & Treatment/Interventions and Service aspects of care. Furthermore, they expanded the taxonomy by twenty-nine categories, establishing a final analytical structure containing eleven domains and seventy-one categories that reflect specialized hospital encounters, diagnostic journeys, and complex clinical interventions.

Analysis of the sixty-one included publications demonstrated substantial disparities in how frequently individual healthcare domains were evaluated. The most widely addressed domains across the literature were Self-management support, identified in eighty-nine percent of papers (fifty-four of sixty-one), People-centredness, present in eighty-seven percent (fifty-three of sixty-one), and Comprehensiveness, examined in eighty percent (fifty of sixty-one). Care Coordination appeared in seventy-two percent of the studies (forty-four of sixty-one), while Access and Overall perceived quality of care were each evaluated in sixty-nine percent (forty-two of sixty-one). In contrast, Continuity was addressed in fifty-seven percent (thirty-five of sixty-one) and Diagnosis & Treatment/Interventions in fifty-four percent (thirty-three of sixty-one). The least investigated areas included Service aspects of care, documented in thirty-three percent of papers (twenty of sixty-one), Trust, explored in twenty-three percent (fourteen of sixty-one), and Safety, which appeared in only thirteen percent (eight of sixty-one). Notably, six of the eight studies assessing safety focused exclusively on cystic fibrosis.

Examination of the seventy-one individual categories revealed specific aspects of care that patients and family carers highlighted most consistently. Within People-centredness and Comprehensiveness, the single most frequently cited category was healthcare professional communication and listening skills, appearing in sixty-four percent of papers (thirty-nine of sixty-one). This was closely followed by access to multidisciplinary care, documented in sixty-two percent of studies (thirty-eight of sixty-one), and patient or carer participation in clinical decision-making, which featured in sixty-one percent (thirty-seven of sixty-one). The study also illuminated pronounced methodological differences between qualitative and quantitative investigations. Qualitative research, encompassing fourteen interview studies, eight focus group investigations, five narrative analyses, and one observational project, proved critical for uncovering nuanced facets of care. Categories concerning comprehensive care, coordination, interpersonal trust, and diagnostic delays were either restricted to or far more prominently represented in qualitative papers, underscoring that rigid quantitative surveys frequently miss relational dynamics and institutional barriers.

The scoping review identified forty-two distinct questionnaires that researchers and clinical teams had utilized to capture rare disease patient experiences. Among these instruments, seventy-one percent (thirty of forty-two) were unvalidated, author-built questionnaires assembled by altering validated measures or combining them with ad hoc questions. The remaining twenty-nine percent (twelve of forty-two) were validated instruments, yet only eight had undergone specific validation for rare diseases. These validated tools were restricted to isolated conditions, including cystic fibrosis, pulmonary arterial hypertension, paediatric cancer, and inflammatory bowel disease, alongside three measures validated for chronic illnesses that included cystic fibrosis cohorts. Only one instrument among all forty-two, the Cystic Fibrosis Patient Experience and Satisfaction with Care Services questionnaire, incorporated items spanning all eleven identified domains, yet even this comprehensive measure evaluated just thirty-one of the seventy-one defined categories. Other validated tools, such as the adolescent-focused Youth Healthcare measure and the parent-proxy Child Healthcare measure, covered nine domains but omitted Trust and Safety.

The authors observed pronounced geographic and clinical concentration within the published evidence base, revealing substantial gaps in representativeness. Single-country studies constituted eighty-five percent of the included literature (fifty-two of sixty-one papers), with investigations heavily clustered in English-speaking and western European nations. The United Kingdom accounted for nineteen publications, the United States for twelve, Germany for twelve, and the Netherlands for ten. Furthermore, single-disease investigations represented fifty-nine percent of the corpus (thirty-five of sixty-one), while multi-disease evaluations comprised forty-one percent (twenty-six of sixty-one). Cystic fibrosis alone formed the subject of twenty-three publications, followed distantly by systemic sclerosis with six, inflammatory bowel disease with five, juvenile arthritis with four, and haemophilia with two. Collectively, all examined conditions accounted for less than two percent of the more than 6,000 recognized rare diseases. This intense clinical concentration demonstrates that current knowledge regarding specialized healthcare experiences is derived from an exceptionally narrow subset of conditions with well-established patient communities.

Demographic reporting across the surveyed literature revealed severe omissions, particularly regarding participant ethnicity and age representation. Only nine of the sixty-one included papers recorded or reported participant race or ethnicity, with eight of these originating in North America and only one in the United Kingdom. Across continental Europe, ethnicity was entirely absent from reported datasets, reflecting systemic regional reluctance to record demographic subcategories despite evidence showing that ethnic minority communities often report poorer healthcare experiences and heightened barriers to specialized care. Age distribution was similarly skewed across the evidence base. Twenty-six publications evaluated purely patient-reported experiences, predominantly among adults over eighteen years old, while parent-proxy studies accounted for eleven papers focusing on paediatric populations. Twenty-four studies combined patient and carer perspectives. Crucially, adolescents represented the single least evaluated age bracket, appearing in only fifteen papers despite facing unique developmental challenges, prolonged diagnostic odysseys, and complex transitions between paediatric and adult secondary services.

The methodological composition of the sixty-one included studies displayed a strong predominance of quantitative survey designs over exploratory qualitative assessments. Sixty-one percent of the publications (thirty-seven of sixty-one) relied entirely on quantitative techniques, exclusively utilizing questionnaire administrations. Qualitative methods appeared in twenty-one percent of studies (thirteen of sixty-one), mixed-methods designs in ten percent (six of sixty-one), and combined qualitative-quantitative tools in eight percent (five of sixty-one). Formal validation activities were reported in sixty-seven percent of the articles (forty-one of sixty-one), distributed across twenty-two quantitative, ten qualitative, five mixed-methods, and four qualitative-quantitative publications. However, patient involvement in research design remained suboptimal: people living with rare diseases, family caregivers, or patient advocacy organisations participated in study design, participant recruitment, or data management in only forty-nine percent of publications (thirty of sixty-one). The authors emphasized that without direct stakeholder collaboration, measurement tools risk evaluating institutional priorities rather than the actual lived challenges of families navigating complex medical services.

To address these systemic gaps, the authors outlined five strategic recommendations to guide the co-creation of a validated healthcare experience framework and generic patient-reported experience measures. First, health systems must involve multiple stakeholders, including patients, family carers, hospital managers, and clinical professionals, ensuring that evaluative metrics reflect lived priorities and practical clinical workflows. Second, future research must expand disease diversity beyond the current two-percent coverage by constructing purposive samples reflecting varied onset ages, genetic backgrounds, disease progression profiles, and disability levels. Third, measurement strategies must cater to all age brackets by developing dedicated self-report tools for adolescents alongside adult questionnaires and caregiver proxy instruments. Fourth, research initiatives must systematically consider gender dynamics and collect ethnicity data to eliminate care disparities. Finally, investigators must ensure broad geographic representation and cross-cultural validation across European healthcare systems, establishing standardized generic instruments that can support hospital accreditation, regional policy decisions, and equitable access to specialized multidisciplinary care.

Subject of Research: Patient-reported experiences and healthcare quality measures for rare diseases in specialized care

Article Title: Patient-reported experiences of people living with a rare disease with secondary and tertiary care: a scoping review

Article References: Francisco, R., Wensing, M., Jones, J., & Dubief, J. (2026). Patient-reported experiences of people living with a rare disease with secondary and tertiary care: a scoping review. Orphanet Journal of Rare Diseases, 21(1), Article 388. https://doi.org/10.1186/s13023-026-04368-5

Image Credits: AI Generated

DOI: 10.1186/s13023-026-04368-5

Keywords: rare diseases, scoping review, patient-reported experience measures, secondary care, tertiary healthcare, healthcare quality, care coordination, patient-centred care, cystic fibrosis, PaRIS survey, healthcare domains, clinical validation, family caregivers, health equity, adolescent healthcare, European Reference Networks, systemic sclerosis, diagnostic delay